Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
Tøri Vigeland Lerum, Niklas Maltzahn, Pål Aukrust, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations
Beate Vestad, Thor Ueland, Tøri Vigeland Lerum, et al.
Journal of Internal Medicine (2022) Vol. 291, Iss. 6, pp. 801-812
Open Access | Times Cited: 58
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
Daniel M. Altmann, Catherine J. Reynolds, George Joy, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Matrix metalloproteinase/Fas ligand (MMP/FasL) interaction dynamics in COVID-19: An in silico study and neuroimmune perspective
Kiarash Saleki, Cena Aram, Parsa Alijanizadeh, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e30898-e30898
Open Access | Times Cited: 10
Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions
Rebecca Salomão, Victória Assis, Ivo Vieira de Sousa Neto, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 843-843
Open Access | Times Cited: 16
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Sylvia Mink, Patrick Reimann, Peter Fraunberger
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1029-1043
Open Access | Times Cited: 6
The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread
Aseel Awad Alsaidan, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 13
Circulating markers of extracellular matrix remodelling in severe COVID‐19 patients
Sarah Louise Murphy, Bente Halvorsen, Jan Cato Holter, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 6, pp. 784-797
Open Access | Times Cited: 12
Escalated complement activation during hospitalization is associated with higher risk of 60‐day mortality in SARS‐CoV‐2‐infected patients
Andreas Barratt‐Due, Kristin Pettersen, Tuva Børresdatter‐Dahl, et al.
Journal of Internal Medicine (2024) Vol. 296, Iss. 1, pp. 80-92
Open Access | Times Cited: 4
Interactions and clinical implications of serological and respiratory variables 3 months after acute COVID-19
Ophir Freund, Anna Breslavsky, Sabrina Fried, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3729-3736
Closed Access | Times Cited: 10
High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
Anders Tveita, Sarah Louise Murphy, Jan Cato Holter, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 12, pp. 2150-2160
Open Access | Times Cited: 17
The role of platelets, neutrophils and endothelium in COVID-19 infection
Emanuela Falcinelli, Eleonora Petito, Paolo Gresele
Expert Review of Hematology (2022) Vol. 15, Iss. 8, pp. 727-745
Closed Access | Times Cited: 12
A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19
Tøri Vigeland Lerum, Carin Meltzer, Jezabel Riverio Rodriguez, et al.
ERJ Open Research (2022) Vol. 9, Iss. 2, pp. 00575-2022
Open Access | Times Cited: 12
Advances in Biomarkers for Diagnosis and Treatment of ARDS
Ruiqi Ge, Shou Zhen Wang, Zhiyong Peng
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3296-3296
Open Access | Times Cited: 7
Shared Inflammatory Pathology of Stroke and COVID-19
Kathryn E. Sánchez, Gary A. Rosenberg
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5150-5150
Open Access | Times Cited: 11
Matrix Metalloproteinases in Health and Disease in the Times of COVID-19
Carlos Fernández-Patrón, Eugenio Hardy
Biomolecules (2022) Vol. 12, Iss. 5, pp. 692-692
Open Access | Times Cited: 11
Distinct Features of Vascular Diseases in COVID-19
Alexandr Ceasovschih, Victorița Șorodoc, Annabelle Shor, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 2783-2800
Open Access | Times Cited: 6
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology
Thor Ueland, Ingvild Hausberg, Trude Victoria Mørtberg, et al.
Platelets (2022) Vol. 33, Iss. 4, pp. 640-644
Open Access | Times Cited: 10
Persistent T‐cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID‐19: Results from two Norwegian cohort studies
Marius Trøseid, Tuva B. Dahl, Jan Cato Holter, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 5, pp. 816-828
Open Access | Times Cited: 9
Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study
Sarah Louise Murphy, Nora Reka Balzer, Trine Ranheim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 – implications for post COVID-19 conditions
Gulrayz Ahmed, Yasir Abdelgadir, Amro Abdelghani, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Elevated matrix metalloproteinase‑9 expression is associated with COVID‑19 severity: A meta‑analysis
Ling Ding, Haipeng Guo, Chao Zhang, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 6
Open Access | Times Cited: 4
Markers of cellular senescence is associated with persistent pulmonary pathology after COVID-19 infection
Tove Lekva, Thor Ueland, Bente Halvorsen, et al.
Infectious Diseases (2022) Vol. 54, Iss. 12, pp. 918-923
Open Access | Times Cited: 6
Long-Term Effects of COVID-19 on Lungs and the Clinical Relevance: A 6-Month Prospective Cohort Study
Gülşah Tunçer, Ceyda Geyiktepe-Güçlü, Serkan Sürme, et al.
Future Microbiology (2023) Vol. 18, Iss. 4, pp. 185-198
Closed Access | Times Cited: 3
Interstitial Pulmonary Fibrosis and Extensive Dendriform Ossification with Persistent Viral Load: A Rare Presentation of Post-COVID-19 Condition in Need of Lung Transplantation
Jasmin D. Haslbauer, Ivana Bratic-Hench, Katharina Cima, et al.
Pathobiology (2022) Vol. 90, Iss. 2, pp. 138-146
Open Access | Times Cited: 5
Association between COVID-19 and Sick Leave for Healthcare Workers in a Large Academic Hospital in Southern Italy: An Observational Study
Raffaele Palladino, Michelangelo Mercogliano, Claudio Fiorilla, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 9670-9670
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top